Literature DB >> 27648137

Aβ mediates Sigma receptor degradation via CaN/NFAT pathway.

Min Fang1, Pei Zhang1, Yanxin Zhao1, Aiping Jin1, Xueyuan Liu1.   

Abstract

Sigma receptor is an endoplasmic reticulum protein and belongs to non-opioid receptor. Increasing evidence shows that Sigma receptor activation can significantly attenuate AD induced neurological dysfunction and the functional deficiency of Sigma receptor plays an important role in the Aβ induced neuronal loss. This study aimed to investigate the influence of extracellular accumulation of Aβ on the Sigma receptor expression. Our results showed the increase in extracellular Aβ had little influence on the mRNA expression of Sigma receptor, but gradually reduced its protein expression. Co-immunoprecipitation was employed to evaluate the interaction of Sigma receptor with other proteins. Results showed BIP could bind to Sigma receptor to affect the ubiquitination of Sigma receptor. Further investigation showed there was a NFAT binding site at the promoter of BIP. Then, Western blot assay was performed to detect NFAT expression. Results showed extracellular Aβ affected the nuclear translocation of NFAT and the CaN activity of NFAT also increased with the accumulation of extracellular Aβ. In this study, NFAT-BIP luciferase reporter gene system was constructed. Results showed NFAT was able to regulate the transcription of BIP. Thus, we speculate that extracellular Aβ accumulation may activate CaN/NFAT signaling pathway to induce chaperone BIP expression, which results in Sigma receptor ubiquitination and its degradation.

Entities:  

Keywords:  Alzheimer disease; calcineurin; nuclear factor of activated T cells; sigma receptor; β-amyloid

Year:  2016        PMID: 27648137      PMCID: PMC5009399     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

1.  Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease.

Authors:  Yue Huang; Lan Zheng; Glenda Halliday; Carol Dobson-Stone; Ying Wang; Hui-Dong Tang; Li Cao; Yu-Lei Deng; Gang Wang; Yu-Mei Zhang; Jian-Hua Wang; Marianne Hallupp; John Kwok; Sheng-Di Chen
Journal:  Curr Alzheimer Res       Date:  2011-11       Impact factor: 3.498

2.  Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data.

Authors:  Camilla Niva; Joanna Parkinson; Fredrik Olsson; Erno van Schaick; Johan Lundkvist; Sandra A G Visser
Journal:  Eur J Clin Pharmacol       Date:  2013-01-04       Impact factor: 2.953

3.  Epidemiology and Clinical Diagnosis: Alzheimer Disease.

Authors:  Robert M Cohen
Journal:  PET Clin       Date:  2013-10-01

4.  Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.

Authors:  Sylvia Villeneuve; Bruce R Reed; Cindee M Madison; Miranka Wirth; Natalie L Marchant; Stephen Kriger; Wendy J Mack; Nerses Sanossian; Charles DeCarli; Helena C Chui; Michael W Weiner; William J Jagust
Journal:  Neurology       Date:  2014-06-06       Impact factor: 9.910

5.  Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.

Authors:  Renzo Mancuso; Sara Oliván; Amaya Rando; Caty Casas; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

6.  Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.

Authors:  Aren van Waarde; Lukas B Been; Kiichi Ishiwata; Rudi A Dierckx; Philip H Elsinga
Journal:  J Nucl Med       Date:  2006-09       Impact factor: 10.057

7.  Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.

Authors:  Julie Blanchard; Lukas Wanka; Yunn-Chyn Tung; María del Carmen Cárdenas-Aguayo; Frank M LaFerla; Khalid Iqbal; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2010-08-10       Impact factor: 17.088

8.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

9.  Association between a variant of the sigma-1 receptor gene and Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Anna László; János Kálmán; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  Neurosci Lett       Date:  2012-04-25       Impact factor: 3.046

10.  Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions.

Authors:  Jose Luis Ortega-Roldan; Felipe Ossa; Jason R Schnell
Journal:  J Biol Chem       Date:  2013-06-12       Impact factor: 5.157

View more
  2 in total

1.  Pin1 mediates Aβ42-induced dendritic spine loss.

Authors:  Nancy R Stallings; Melissa A O'Neal; Jie Hu; Ege T Kavalali; Ilya Bezprozvanny; James S Malter
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

2.  Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases.

Authors:  Pradoldej Sompol; Christopher M Norris
Journal:  Front Aging Neurosci       Date:  2018-07-09       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.